The reduction in growth rate as an apparent additional feature of MEK inhibition in non-small cell lung cancer tumour initiating cells was already mentioned in (Lundholm et al. 2014), but there we did not have any tool to measure it quantitatively. The gene discussed is MAP2K7; the disease is non-small cell lung carcinoma.